Literature DB >> 25132370

Clinical phenotype and genetic analysis of RPS19, RPL5, and RPL11 genes in Greek patients with Diamond Blackfan Anemia.

Polyxeni Delaporta1, Christalena Sofocleous, Eftichia Stiakaki, Sophia Polychronopoulou, Marina Economou, Lydia Kossiva, Stavroula Kostaridou, Antonis Kattamis.   

Abstract

BACKGROUND: Diamond Blackfan Anemia (DBA) is a rare congenital, bone marrow failure syndrome characterized by normochromic macrocytic anemia, reticulocytopenia and absence or insufficiency of erythroid precursors in normocellular bone marrow, frequently associated with somatic malformations. Here, we present our findings from the study of 17 patients recorded in the Greek DBA registry. PROCEDURE: Clinical evaluation of patients and data collection was performed followed by the molecular analysis of RPS19, RPL5, and RPL11 genes. Mutation screening included PCR amplification, ECMA analysis, and direct sequencing.
RESULTS: Congenital anomalies were observed in 71% of the patients. Six patients (35.2%) were found to carry mutations on either the RPS19 gene (three patients,) or the RPL5 gene (three patients). Mutations c.C390G (p.Y130X) and c.197_198insA (p.Y66X) detected in the RPL5 gene were novel. No mutations at the RPL11 gene were identified in Greek patients with DBA.
CONCLUSIONS: The clinical course of the patients was similar to previous reports. The occurrence of thyroid carcinoma in an adult patient with DBA is the first to be reported in DBA.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  bone marrow failure; cancer predisposition; diamond Blackfan Anemia (DBA)

Mesh:

Substances:

Year:  2014        PMID: 25132370     DOI: 10.1002/pbc.25183

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

1.  A Novel Mutation of Ribosomal Protein S19 Gene in a Chinese Child with Diamond-Blackfan Anemia.

Authors:  Hua Jiang; Man-Yu Wu; Dong-Zhi Li
Journal:  Indian J Hematol Blood Transfus       Date:  2015-03-13       Impact factor: 0.900

Review 2.  Developmental processes regulate craniofacial variation in disease and evolution.

Authors:  Fjodor Merkuri; Jennifer L Fish
Journal:  Genesis       Date:  2018-10-01       Impact factor: 2.487

3.  Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint.

Authors:  Ines Oršolić; Slađana Bursać; Deana Jurada; Irena Drmić Hofman; Zlatko Dembić; Jiri Bartek; Ivana Mihalek; Siniša Volarević
Journal:  Oncogene       Date:  2020-02-27       Impact factor: 9.867

Review 4.  Nonsense Suppression Therapy: New Hypothesis for the Treatment of Inherited Bone Marrow Failure Syndromes.

Authors:  Valentino Bezzerri; Martina Api; Marisole Allegri; Benedetta Fabrizzi; Seth J Corey; Marco Cipolli
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 5.  Ribosomopathies: Global process, tissue specific defects.

Authors:  Pamela C Yelick; Paul A Trainor
Journal:  Rare Dis       Date:  2015-04-01

6.  A functional assay for the clinical annotation of genetic variants of uncertain significance in Diamond-Blackfan anemia.

Authors:  Anna Aspesi; Marta Betti; Marika Sculco; Chiara Actis; Cristina Olgasi; Marcin W Wlodarski; Adrianna Vlachos; Jeffrey M Lipton; Ugo Ramenghi; Claudio Santoro; Antonia Follenzi; Steven R Ellis; Irma Dianzani
Journal:  Hum Mutat       Date:  2018-05-28       Impact factor: 4.878

7.  Genotype-phenotype association and variant characterization in Diamond-Blackfan anemia caused by pathogenic variants in RPL35A.

Authors:  Matthew D Gianferante; Marcin W Wlodarski; Evangelia Atsidaftos; Lydie Da Costa; Polyxeni Delaporta; Jason E Farrar; Frederick D Goldman; Maryam Hussain; Antonis Kattamis; Thierry Leblanc; Jeffrey M Lipton; Charlotte M Niemeyer; Dagmar Pospisilova; Paola Quarello; Ugo Ramenghi; Vijay G Sankaran; Adrianna Vlachos; Jana Volejnikova; Blanche P Alter; Sharon A Savage; Neelam Giri
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.